Hypofractionated Radiotherapy with a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer

Sponsor:
MUSC
Sponsor Study ID:
104214
CTO #:
104214
NCT Number:
NCT07325721
Phase:
II
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Prostate
Study Objectives:
To evaluate the incidence of CTCAE grade 2 or higher acute genitourinary (GU) toxicity.
eConsent:
Not available
Study Documents:
Open Study Documents
(MUSC NetID required for document access)

For more information about this trial please contact the study team:

  • Medical University of South Carolina

Trial opened at the following institutions:

Medical University of South Carolina